Proteomics of MCF7 cells (LC-MS/MS Orbitrap Fusion Tribrid)

ABSTRACT: We developed RiboLace, a novel method based on a new puromycin-containing molecule, for the isolation of active ribosomes and associate RNAs by means of an antibody-free and tag-free pull-down approach. We compared riboLace translation estimates with protein levels determined by proteomics in MCF7 cells. RiboLace can be easily and rapidly used to obtain a transcriptome-wide snapshot of active translation from eukaryotic in vitro and in vivo systems.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Permanent Cell Line Cell, Epithelial Cell, Cell Culture

DISEASE(S): Breast Cancer

SUBMITTER: Toma Tebaldi  

LAB HEAD: Gabriella Viero

PROVIDER: PXD009417 | Pride | 2018-11-21

REPOSITORIES: Pride